Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) SHH

12.16

+1.11(+10.05%)

Updated at August 19 03:00PM

Currency In CNY

Valuation

Market Cap3.56B
Enterprise Value4.93B
P/E Ratio-119.75
PEG Ratio11.97
Price/Sales Ratio2.16
Price/Book Ratio2.13
Enterprise/Revenue2.88
Enterprise/EBITDA73.54

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.02
Operating Margin-0.01

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue2.35B
Revenue/Share5
Gross Profit456.73M
EBITDA261.16M
Net Income-49.1M
Diluted EPS-0.12

Balance Sheet

Total Cash411.42M
Total Cash/Share1.19
Total Debt2.13B
Total Debt/Equity0.81
Current Ratio0.83
Book Value Per Share5.54

Price History

52-Week Change30.17
52-Week High11.79
52-Week Low7.32
Moving Average 50 Days10.35
Moving Average 200 Days9.3

Statistics

Average Volume14.07M
Shares Outstanding438.41M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield1.27
Payout Ratio-2.68
Last Split Factor7:5
Last Split DateJune 17, 2022